Assenagon Asset Management’s Cardiff Oncology CRDF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Hold |
67,231
| – | – | ﹤0.01% | 1093 |
|
|
2025
Q1 | $211K | Hold |
67,231
| – | – | ﹤0.01% | 1083 |
|
|
2024
Q4 | $292K | Sell |
67,231
-203,292
| -75% | -$882K | ﹤0.01% | 1224 |
|
|
2024
Q3 | $722K | Sell |
270,523
-945,399
| -78% | -$2.52M | ﹤0.01% | 1159 |
|
|
2024
Q2 | $2.7M | Buy |
1,215,922
+962,940
| +381% | +$2.14M | 0.01% | 788 |
|
|
2024
Q1 | $1.35M | Buy |
+252,982
| New | +$1.35M | ﹤0.01% | 966 |
|
|
2023
Q4 | – | Sell |
-84,272
| Closed | -$117K | – | 1372 |
|
|
2023
Q3 | $117K | Sell |
84,272
-58,156
| -41% | -$80.8K | ﹤0.01% | 1307 |
|
|
2023
Q2 | $209K | Sell |
142,428
-252,566
| -64% | -$371K | ﹤0.01% | 1236 |
|
|
2023
Q1 | $652K | Buy |
394,994
+215,451
| +120% | +$355K | ﹤0.01% | 1123 |
|
|
2022
Q4 | $251K | Buy |
179,543
+13,009
| +8% | +$18.2K | ﹤0.01% | 1232 |
|
|
2022
Q3 | $256K | Buy |
166,534
+11,344
| +7% | +$17.4K | ﹤0.01% | 1194 |
|
|
2022
Q2 | $341K | Sell |
155,190
-169,270
| -52% | -$372K | ﹤0.01% | 1258 |
|
|
2022
Q1 | $805K | Buy |
+324,460
| New | +$805K | ﹤0.01% | 1061 |
|
|
2021
Q3 | – | Sell |
-26,167
| Closed | -$174K | – | 1270 |
|
|
2021
Q2 | $174K | Buy |
+26,167
| New | +$174K | ﹤0.01% | 1114 |
|